https://cytel.agencyukdev.com/perspectives/career-perspectives-a-conversation-with-veronica-chan/ 2024-06-27T19:10:50+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1224403019_abstract.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Career-Perspectives_Veronica-Chan_Quote1.webp https://cytel.agencyukdev.com/perspectives/how-can-we-tackle-heterogeneity-in-meta-analysis/ 2024-06-28T06:28:09+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/ForestPlot1Metaanalysis.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Forestplotfigure1.webp https://cytel.agencyukdev.com/perspectives/linked-data-studies-improving-the-way-we-do-observational-research-in-germany/ 2024-06-28T06:39:21+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_Abstract_11.jpg https://cytel.agencyukdev.com/perspectives/patient-journey-centric-study-designs-in-clinical-trials-a-cro-perspective/ 2024-07-18T14:00:20+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-02.jpg https://cytel.agencyukdev.com/perspectives/the-role-of-external-data-in-oncology-drug-development/ 2024-08-06T10:48:19+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/08/ECA-Blog-graphic-1.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/08/ECA-Blog-graphic-2.jpg https://cytel.agencyukdev.com/perspectives/career-perspectives-a-conversation-with-arnold-van-aswegen/ 2024-08-21T13:19:44+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1470900675_abstract.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Casual-Arnold-van-Aswegen.webp https://cytel.agencyukdev.com/perspectives/reintegration-dilemma-integrated-summaries-of-safety-and-effectiveness/ 2024-08-21T14:53:16+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1459944177_abstract.jpg https://cytel.agencyukdev.com/perspectives/2015-highlights-seamless-adaptive-clinical-trials-now-that-we-get-the-statistics-whats-really-at-stake/ 2024-08-21T14:53:39+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/5-steps-to-adjust-for-effect-modifiers-for-treatment-comparisons/ 2024-08-21T14:53:58+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1364191123_abstract.jpg https://cytel.agencyukdev.com/perspectives/6-steps-to-timely-database-lock/ 2024-08-21T14:54:21+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1459944177_abstract.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/databaselock.webp https://cytel.agencyukdev.com/perspectives/7-ways-rwd-is-transforming-clinical-research/ 2024-08-21T14:55:01+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-2069659353_abstract-scaled.jpg https://cytel.agencyukdev.com/perspectives/a-better-way-to-track-medication-adherence/ 2024-08-21T14:55:24+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-05.jpg https://cytel.agencyukdev.com/perspectives/a-data-managers-role-in-supporting-a-rare-disease-clinical-study/ 2024-08-21T14:55:55+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_Abstract_11.jpg https://cytel.agencyukdev.com/perspectives/a-look-ahead-for-2023/ 2024-08-21T14:56:14+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-01.jpg https://cytel.agencyukdev.com/perspectives/a-preview-of-cytels-contributions-to-phuse-eu-2022/ 2024-08-21T14:57:16+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-02.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/header_Good_Data_doctor.webp https://cytel.agencyukdev.com/perspectives/a-spotlight-on-fsp-programming/ 2024-08-21T14:57:37+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-03.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Career-Perspectives_FSP-Quotes.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Career-Perspectives_FSP-Quotes2.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Career-Perspectives_FSP-Quotes3.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Career-Perspectives_FSP-Quotes4.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Career-Perspectives_FSP-Quotes5.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Career-Perspectives_FSP-Quotes6.webp https://cytel.agencyukdev.com/perspectives/accelerating-development-with-combined-sad-mad-approach/ 2024-08-21T14:58:17+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-06.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/SADMAD.webp https://cytel.agencyukdev.com/perspectives/accrual-when-starting-a-platform-trial-vs-in-a-stand-alone-trial/ 2024-08-21T14:58:36+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-07.jpg https://cytel.agencyukdev.com/perspectives/adaptive-designs-are-re-defining-drug-development-learn-whats-new/ 2024-08-21T14:58:53+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-08.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/7.28_Fig1.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/7.28_Fig2.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/7.28_Fig3.webp https://cytel.agencyukdev.com/perspectives/adaptive-designs-for-early-phase-development-are-the-questions-right/ 2024-08-21T15:02:09+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-09.jpg https://cytel.agencyukdev.com/perspectives/adaptive-multi-arm-multi-stage-designs-a-comparison-of-methods/ 2024-08-21T15:02:30+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-10.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Mehta_Adaptive-MAMS-Designs_Fig1-01-1.webp https://cytel.agencyukdev.com/perspectives/adaptive-trials-at-the-mainstream-of-drug-development/ 2024-08-21T15:02:50+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/8.12_Adaptive_Fig1-01.webp https://cytel.agencyukdev.com/perspectives/advancing-oncology-trials-with-bayesian-basket-designs/ 2024-08-21T15:03:25+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1470900662_abstract.jpg https://cytel.agencyukdev.com/perspectives/aligning-clinical-trial-design-with-investment-priorities/ 2024-08-21T15:03:42+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-11.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Investment-Priorities_Fig1-01.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Investment-Priorities_Fig3-4-01.webp https://cytel.agencyukdev.com/perspectives/an-introduction-to-blrm/ 2024-08-21T15:04:26+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-07.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/East_ESCALATE_video_2.webp https://cytel.agencyukdev.com/perspectives/apac-biopharma-industry-insights-trends-opportunities-and-challenges/ 2024-08-21T15:05:32+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1470900662_abstract.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/APAC-series_Fig1.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/APAC-series_Fig2.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/APAC-series_Fig3.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/APAC-series_Fig4.webp https://cytel.agencyukdev.com/perspectives/artificial-intelligence-applications-in-heor/ 2024-08-21T15:06:05+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-03.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/08/AI-in-HEOR-Table-1-e1722943708997.png https://cytel.agencyukdev.com/wp-content/uploads/2024/08/AI-in-HEOR-Fig-1.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/08/AI-in-HEOR-Fig-2.jpg https://cytel.agencyukdev.com/perspectives/balancing-real-world-data-quality-vs-locality/ 2024-08-21T15:06:25+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/ISPOR-P2-Grammati-banner.webp https://cytel.agencyukdev.com/perspectives/bayesian-adaptive-clinical-trial-designs-inla-vs-mcmc/ 2024-08-21T15:06:43+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1470900662_abstract.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Krishna-Padmanabhan_INLA-vs-MCMC_Fig1.webp https://cytel.agencyukdev.com/perspectives/bayesian-approach-in-oncology-trials/ 2024-08-21T15:07:15+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/bayesian-hierarchical-modelling-for-histology-independent-therapies/ 2024-08-21T15:07:31+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-09.jpg https://cytel.agencyukdev.com/perspectives/bayesian-methods-for-historical-borrowing-conjugate-priors/ 2024-08-21T15:07:59+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/bayesian-statistics-and-its-applications-new-webinar-by-professor-yuan-ji/ 2024-08-21T15:08:17+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1438242735_abstract.jpg https://cytel.agencyukdev.com/perspectives/bayesian-strategies-in-rare-diseases/ 2024-08-21T15:08:46+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/behind-the-oncology-research-an-interview-between-robert-szulkin-and-jana-de-boniface/ 2024-08-21T15:09:06+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1135527896_abstract.jpg https://cytel.agencyukdev.com/perspectives/bridging-the-gap-between-oncology-clinical-trials-and-real-world-data-evidence-on-replicability-of-efficacy-results-using-german-claims-data/ 2024-08-21T15:09:26+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1470900662_abstract.jpg https://cytel.agencyukdev.com/perspectives/career-perspectives-a-conversation-with-deqing-pei/ 2024-08-21T15:09:50+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-626349894_abstract-e1718646801522.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/07/Deqng-Pei.png https://cytel.agencyukdev.com/perspectives/career-perspectives-a-conversation-with-emily-woolley/ 2024-08-21T15:10:35+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-11.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/CP_Emily-Woolley_Image1.webp https://cytel.agencyukdev.com/perspectives/career-perspectives-a-conversation-with-joshua-murray/ 2024-08-21T15:11:29+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-12.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Joshua-Murray-traveling.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Joshua-Murray_curling.webp https://cytel.agencyukdev.com/perspectives/career-perspectives-a-conversation-with-karl-karu/ 2024-08-21T15:11:48+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-626349894_abstract-e1718646801522.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/medium.jpg https://cytel.agencyukdev.com/perspectives/career-perspectives-a-conversation-with-kumkuen-yuen/ 2024-08-21T15:12:04+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1438242735_abstract.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Career-Perspectives_Yuen_Quote1.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/KumKuenYuen2.webp https://cytel.agencyukdev.com/perspectives/career-perspectives-a-conversation-with-malte-stein/ 2024-08-21T15:12:20+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1135527896_abstract.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/CP_Malte-Stein_Quote.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Malte-Stein-photo.webp https://cytel.agencyukdev.com/perspectives/career-perspectives-a-conversation-with-nicolas-rouille/ 2024-08-21T15:12:43+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1364191123-_abstract-scaled.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/CP_quote1.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/CP_quote2.webp https://cytel.agencyukdev.com/perspectives/career-perspectives-a-conversation-with-pratibha-jalui/ 2024-08-21T15:13:06+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-03.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Career-Perspectives_PratibhaJalui_Quote1.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Career-Perspectives_PratibhaJalui_Quote2.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Pratibha_TravelPic.webp https://cytel.agencyukdev.com/perspectives/interview-with-allison-luccock-about-career-perspectives/ 2024-08-21T15:14:02+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Allison-L_2.webp https://cytel.agencyukdev.com/perspectives/career-perspectives-interview-with-charles-warne-associate-director-of-biostatistics/ 2024-08-21T15:14:25+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-07.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Capture2.webp https://cytel.agencyukdev.com/perspectives/career-perspectives-interview-with-jessica-bhoyroo-clinical-data-manager/ 2024-08-21T15:14:43+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-01.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Picture-2.webp https://cytel.agencyukdev.com/perspectives/career-perspectives-reflecting-at-10-years-in-cytel-fsp/ 2024-08-21T15:15:06+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Anwaya-Joshi-x-400.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Srinivasreddy-Atla-x-400.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Sneha-Naware-x-400.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Sagar_Gore-x400.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Pallavi_Jagtap-x-400.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Harshavardhan-Yatirajula-x-400.webp https://cytel.agencyukdev.com/perspectives/cdisc-certification-is-it-worth-taking/ 2024-08-21T15:15:24+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-06.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/image-png-Aug-23-2021-12-03-32-49-PM.webp https://cytel.agencyukdev.com/perspectives/cdisc-europe-2023-a-preview/ 2024-08-21T15:15:48+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-957206588_abstract-scaled.jpg https://cytel.agencyukdev.com/perspectives/cdisc-sdtm-and-adam-an-explosive-2021-ending/ 2024-08-21T15:16:16+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Header-V1.2.webp https://cytel.agencyukdev.com/perspectives/celebrating-35-years-of-innovation-and-impact-an-interview-series/ 2024-08-21T15:16:49+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/35th-anniversary-ebook-blog-banner.webp https://cytel.agencyukdev.com/perspectives/commercial-and-open-source-software-synergy-for-clinical-trial-design/ 2024-08-21T15:17:08+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-01.jpg https://cytel.agencyukdev.com/perspectives/comparative-effectiveness-methods-and-techniques-for-better-decision-making/ 2024-08-21T15:17:29+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1470900662_abstract.jpg https://cytel.agencyukdev.com/perspectives/conduct-of-idmcs-for-cell-and-gene-therapy-trials/ 2024-08-21T15:17:52+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-2069659353_abstract-scaled.jpg https://cytel.agencyukdev.com/perspectives/continuous-monitoring-for-blinded-sample-size-reestimation/ 2024-08-21T15:18:24+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-13.jpg https://cytel.agencyukdev.com/perspectives/cyrus-mehta-on-the-founding-of-cytel/ 2024-08-21T15:19:15+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/cytel-present-at-the-asa-biopharmaceutical-section-regulatory-workshop/ 2024-08-21T15:19:32+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-01.jpg https://cytel.agencyukdev.com/perspectives/cytel-publishes-inaugural-sustainability-report/ 2024-08-21T15:19:49+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1470900662_abstract.jpg https://cytel.agencyukdev.com/perspectives/data-capture-and-data-sharing-during-the-covid-19-pandemic/ 2024-08-21T15:20:06+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-01.jpg https://cytel.agencyukdev.com/perspectives/data-challenges-and-solutions-for-externally-controlled-trials/ 2024-08-21T15:20:22+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1364191123-_abstract-scaled.jpg https://cytel.agencyukdev.com/perspectives/data-monitoring-committees-for-phase-1-clinical-trials/ 2024-08-21T15:21:31+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-957206588_abstract-scaled.jpg https://cytel.agencyukdev.com/perspectives/data-centric-approaches-to-streamline-the-clinical-workload/ 2024-08-21T15:22:04+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/decision-making-in-early-clinical-development/ 2024-08-21T16:03:58+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/PaulFrewer.webp https://cytel.agencyukdev.com/perspectives/defining-probability-of-success-in-clinical-trial-design-with-commercial-software-and-r-coding/ 2024-08-21T16:04:17+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-05.jpg https://cytel.agencyukdev.com/perspectives/design-considerations-for-early-phase-trials-of-immuno-oncology-drugs/ 2024-08-21T16:04:35+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/developing-a-new-drug-candidate-from-nonclinical-to-first-in-human/ 2024-08-21T16:04:53+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-10.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Andersson_Dicot-LIB-01_Fig1-01.webp https://cytel.agencyukdev.com/perspectives/developing-synthetic-control-arms-using-bayesian-models/ 2024-08-21T16:05:14+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1364191123_abstract.jpg https://cytel.agencyukdev.com/perspectives/differentiating-your-inflammatory-disease-product-common-challenges/ 2024-08-21T16:05:59+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-12.jpg https://cytel.agencyukdev.com/perspectives/dont-forget-the-development-of-your-placebo-overcoming-common-obstacles/ 2024-08-21T16:06:24+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/drug-manufacturer-auditing-ensuring-quality-control-and-safety/ 2024-08-21T16:06:41+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-12.jpg https://cytel.agencyukdev.com/perspectives/dynamic-bayesian-borrowing-to-bolster-limited-sample-sizes-in-rare-indications/ 2024-08-21T16:06:59+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/early-planning-strategies-for-external-control-arms-in-hta-and-regulatory-submissions/ 2024-08-21T16:07:26+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Simeone_Hsu_Merinopoulou_ECAs_Fig1.webp https://cytel.agencyukdev.com/perspectives/embracing-ai-and-ml-in-medical-devices-fdas-total-product-lifecycle-based-regulatory-framework/ 2024-08-21T16:07:43+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-07.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Arora_Fei_AI-ML-FDA_Fig-1.webp https://cytel.agencyukdev.com/perspectives/embracing-evolution-welcome-to-the-new-cytel/ 2024-08-21T16:08:32+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-2069659353_abstract-scaled.jpg https://cytel.agencyukdev.com/perspectives/embracing-innovation-exploring-the-design-of-umbrella-and-basket-trials/ 2024-08-21T16:08:48+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/epidemiological-methods-to-tackle-real-world-evidence-challenges/ 2024-08-21T16:09:11+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1364191123-_abstract-scaled.jpg https://cytel.agencyukdev.com/perspectives/erika-spens-on-developing-your-regulatory-strategy/ 2024-08-21T16:09:31+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1224403019_abstract.jpg https://cytel.agencyukdev.com/perspectives/estimator-choice-in-synthetic-control-arm-analyses/ 2024-08-21T16:09:51+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1470900662_abstract.jpg https://cytel.agencyukdev.com/perspectives/experiencing-the-cber-anticipating-unique-challenges/ 2024-08-21T16:10:08+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-03.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Tinazzi_CBER_Fig1.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Tinazzi_CBER_Fig2.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Tinazzi_CBER_Fig3.webp https://cytel.agencyukdev.com/perspectives/external-validity-bias-in-hta-submissions-a-case-for-transportability-methods/ 2024-08-21T16:10:30+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1135527896_abstract.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/08/Slide1.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/08/Slide2.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/08/Slide3.jpg https://cytel.agencyukdev.com/perspectives/fda-guidance-on-the-design-and-conduct-of-externally-controlled-trials-what-to-watch/ 2024-08-21T16:10:51+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-05.jpg https://cytel.agencyukdev.com/perspectives/fda-increases-calls-for-manufacturers-to-ensure-trial-diversity-but-does-it-fall-short-of-addressing-health-inequalities-in-product-development/ 2024-08-21T16:11:30+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-957206588_abstract-scaled.jpg https://cytel.agencyukdev.com/perspectives/fdas-project-optimus-redefining-oncology-drug-dosage-for-better-patient-outcomes/ 2024-08-22T09:30:53+00:00 https://cytel.agencyukdev.com/perspectives/first-in-human-drug-substance-and-formulation-the-challenge-of-achieving-flexibility-and-quality/ 2024-08-22T09:31:17+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1470900675_abstract.jpg https://cytel.agencyukdev.com/perspectives/fsp-behind-the-scenes-with-anwaya-joshi-programming-senior-team-lead/ 2024-08-22T09:31:37+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/fsp-behind-the-scenes-with-brooke-smith-senior-biostatistician/ 2024-08-22T09:32:00+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-12.jpg https://cytel.agencyukdev.com/perspectives/fsp-behind-the-scenes-with-jeff-thompson-r-senior-statistical-programmer/ 2024-08-22T09:32:22+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-05.jpg https://cytel.agencyukdev.com/perspectives/fsp-behind-the-scenes-with-nandan-kothavale-programming-senior-team-lead/ 2024-08-22T09:32:54+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1438242735_abstract.jpg https://cytel.agencyukdev.com/perspectives/global-planning-to-local-execution-market-success/ 2024-08-22T09:33:20+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/cytel-rwaa-infographic.webp https://cytel.agencyukdev.com/perspectives/guidelines-are-not-instruction-manuals-customize-your-way-to-first-in-human-clinical-trials/ 2024-08-22T09:33:41+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1135527896_abstract.jpg https://cytel.agencyukdev.com/perspectives/highlights-from-the-2024-cdisc-tmf-eu-interchange-in-berlin/ 2024-08-22T09:34:00+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1135527896_abstract.jpg https://cytel.agencyukdev.com/perspectives/how-and-why-to-implement-optimal-adaptive-promising-zone-designs/ 2024-08-22T09:34:32+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-06.jpg https://cytel.agencyukdev.com/perspectives/how-can-an-optimized-data-strategy-support-your-clinical-program/ 2024-08-22T09:34:50+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/how-target-trial-emulation-can-take-the-guesswork-out-of-comparative-effect-estimates-in-medicare-drug-price-negotiation/ 2024-08-22T09:40:23+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-02.jpg https://cytel.agencyukdev.com/perspectives/how-to-ask-the-right-questions-at-an-authority-meeting/ 2024-08-22T09:40:42+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1224403019_abstract.jpg https://cytel.agencyukdev.com/perspectives/how-to-conduct-better-time-to-event-analysis-with-delayed-treatment-effects/ 2024-08-22T09:41:01+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-09.jpg https://cytel.agencyukdev.com/perspectives/how-to-create-and-optimize-a-clinical-development-plan/ 2024-08-22T09:41:25+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1224403019_abstract.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/ClinicalDevPlan_Infographic-01-1.webp https://cytel.agencyukdev.com/perspectives/how-to-determine-if-your-clinical-trial-has-sufficient-data/ 2024-08-22T09:41:47+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-03.jpg https://cytel.agencyukdev.com/perspectives/how-to-ensure-your-adaptive-trial-is-appropriate-for-regulatory-submission/ 2024-08-22T09:42:03+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1364191123_abstract.jpg https://cytel.agencyukdev.com/perspectives/how-to-overcome-common-challenges-to-patient-recruitment-projections/ 2024-08-22T09:42:22+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-12.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/image-png-Feb-03-2022-04-34-40-18-AM.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/image-png-Feb-03-2022-04-44-28-13-AM.webp https://cytel.agencyukdev.com/perspectives/how-to-save-time-and-limit-costs-toward-first-in-human-clinical-trials/ 2024-08-22T09:42:42+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/how-to-use-a-living-hta-approach-to-demonstrate-value-in-real-time/ 2024-08-22T09:43:45+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-04.jpg https://cytel.agencyukdev.com/perspectives/how-to-use-historical-data-to-mitigate-clinical-trial-risk/ 2024-08-22T09:44:08+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-01.jpg https://cytel.agencyukdev.com/perspectives/industry-voices-yannis-jemiai-on-simulation-guided-design-and-the-changing-landscape-of-clinical-trial-strategy/ 2024-08-22T09:44:25+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1224403019_abstract.jpg https://cytel.agencyukdev.com/perspectives/innovative-clinical-trial-design-commercial-vs-open-source-software-why-not-both/ 2024-08-22T09:44:45+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-07.jpg https://cytel.agencyukdev.com/perspectives/insights-on-the-new-adam-guidelines-and-europe-interchange-2022/ 2024-08-22T09:45:01+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-02.jpg https://cytel.agencyukdev.com/perspectives/interview-with-grammati-sarri-on-moderating-an-issue-panel-2022/ 2024-08-22T09:45:33+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1388001249-scaled.jpg https://cytel.agencyukdev.com/perspectives/introduction-to-evidence-synthesis-and-bayesian-dynamic-borrowing/ 2024-08-22T09:45:53+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/its-time-to-move-time-to-move-to-define-xml-2-1/ 2024-08-22T09:46:14+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1224403019_abstract.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/GDD_DefineXLM21_Fig1.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/GDD_DefineXLM21_Fig2.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/GDD_DefineXLM21_Fig4_v2.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/GDD_DefineXLM21_Fig5.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/GDD_DefineXLM21_Fig6.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/GDD_DefineXLM21_Fig7_v2.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/GDD_DefineXLM21_Fig8_v2.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/GDD_DefineXLM21_Fig9_v2.webp https://cytel.agencyukdev.com/perspectives/key-elements-and-implications-of-the-draft-eu-jca-implementing-act/ 2024-08-22T09:46:33+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1470900675_abstract.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Vinals_Sarri_EU_JCA_Fig1.webp https://cytel.agencyukdev.com/perspectives/late-stage-clinical-development-strategy-trade-offs-and-decision-making-in-the-confirmatory-setting/ 2024-08-22T09:46:51+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1364191123-_abstract-scaled.jpg https://cytel.agencyukdev.com/perspectives/living-slrs-and-the-rise-of-digital-technology/ 2024-08-22T09:48:02+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1224403019_abstract.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Diamond_Rizzo_Living-SLRs_Fig1-01.webp https://cytel.agencyukdev.com/perspectives/looking-to-the-future-improving-diagnosis-and-prognosis-of-eye-conditions-with-artificial-intelligence/ 2024-08-22T09:48:44+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-11.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Hari-Patel_crop-1.webp https://cytel.agencyukdev.com/perspectives/managing-uncertainty-simulation-based-assurance-in-clinical-trial-design/ 2024-08-22T09:49:00+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/maria-lundberg-on-a-holistic-approach-to-therapeutics-development/ 2024-08-22T09:49:16+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1388001249-scaled.jpg https://cytel.agencyukdev.com/perspectives/maximizing-study-momentum-a-case-study-in-accelerated-dmc-safety-report-creation-through-idmc-solutions/ 2024-08-22T09:49:37+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-2069659353_abstract-scaled.jpg https://cytel.agencyukdev.com/perspectives/mcmc-vs-inla-in-bayesian-adaptive-clinical-trial-designs/ 2024-08-22T09:49:55+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1388001249-scaled.jpg https://cytel.agencyukdev.com/perspectives/measuring-estimates-and-confidence-intervals-in-adaptive-settings/ 2024-08-22T09:51:18+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1364191123_abstract.jpg https://cytel.agencyukdev.com/perspectives/measuring-robustness-of-clinical-trial-designs-with-pressure-tests/ 2024-08-22T09:51:40+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-11.jpg https://cytel.agencyukdev.com/perspectives/metadata-repositories-overcoming-challenges-with-automation/ 2024-08-22T09:52:58+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1224403019_abstract.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Tinazzi_Metadata_Fig1.webp https://cytel.agencyukdev.com/perspectives/method-of-estimation-with-application-to-the-covid-19-pandemic/ 2024-08-22T09:53:16+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-13.jpg https://cytel.agencyukdev.com/perspectives/mind-the-health-gap-is-it-time-to-reliably-measure-the-impact-of-health-inequity-in-product-development-and-assessment-yes-it-is/ 2024-08-22T09:53:34+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-12.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Sarri_Mind-the-Health-Gap_figure1.webp https://cytel.agencyukdev.com/perspectives/myth-busting-master-protocol-edition/ 2024-08-22T09:53:53+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1470900662_abstract.jpg https://cytel.agencyukdev.com/perspectives/navigating-comparative-effectiveness-in-the-inflation-reduction-act-methodological-approaches-for-healthcare-challenges/ 2024-08-22T09:54:10+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1388001249-scaled.jpg https://cytel.agencyukdev.com/perspectives/navigating-the-clinical-development-landscape-insights-for-success-in-2024/ 2024-08-22T09:54:30+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1470900675_abstract.jpg https://cytel.agencyukdev.com/perspectives/negative-binomial-distribution-in-group-sequential-designs/ 2024-08-22T09:54:46+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/network-meta-interpolation-effect-modification-adjustment-in-network-meta-analysis-using-subgroup-analyses/ 2024-08-22T09:55:04+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-03.jpg https://cytel.agencyukdev.com/perspectives/new-cadth-guidance-on-rwe-is-now-available-but-critical-aspects-are-still-missing/ 2024-08-22T09:55:21+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-10.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Grammati-Sarri_CADTH-RWE_Figure1.webp https://cytel.agencyukdev.com/perspectives/new-directions-in-indirect-treatment-comparisons/ 2024-08-22T09:55:50+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1364191123-_abstract-scaled.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/7.28_Fig1-1.webp https://cytel.agencyukdev.com/perspectives/new-fda-data-submission-requirements-and-substantial-changes/ 2024-08-22T09:56:22+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-13.jpg https://cytel.agencyukdev.com/perspectives/new-fda-guidelines-on-pediatric-studies-and-potential-effects-on-opportunities-for-market-exclusivity/ 2024-08-22T09:56:39+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1388001249-scaled.jpg https://cytel.agencyukdev.com/perspectives/new-linked-database-expands-potential-of-rwe-a-unique-opportunity-for-multiple-sclerosis-research/ 2024-08-22T09:57:17+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-04.jpg https://cytel.agencyukdev.com/perspectives/news-from-esmo-challenging-the-status-quo-of-early-phase-clinical-trial-design-moving-from-why-to-how/ 2024-08-22T09:57:41+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-12.jpg https://cytel.agencyukdev.com/perspectives/nitin-patel-on-35-years-of-technological-innovation/ 2024-08-22T10:01:23+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-13.jpg https://cytel.agencyukdev.com/perspectives/on-frequentist-and-bayesian-sequential-clinical-trial-designs/ 2024-08-22T10:02:05+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1470900675_abstract.jpg https://cytel.agencyukdev.com/perspectives/on-kapplers-graphical-comparison-of-simon-two-stage-designs/ 2024-08-22T10:02:28+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-02.jpg https://cytel.agencyukdev.com/perspectives/operationally-seamless-inferentially-seamless-adaptive-designs/ 2024-08-22T10:02:54+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-03.jpg https://cytel.agencyukdev.com/perspectives/optimizing-early-clinical-development-strategy/ 2024-08-22T10:04:31+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-2069659353_abstract-scaled.jpg https://cytel.agencyukdev.com/perspectives/orphan-drug-designation-for-rare-diseases/ 2024-08-22T10:04:48+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-957206588_abstract-scaled.jpg https://cytel.agencyukdev.com/perspectives/overcoming-the-shared-effect-modifier-assumption-with-network-meta-interpolation/ 2024-08-22T10:05:05+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-626349894_abstract-e1718646801522.jpg https://cytel.agencyukdev.com/perspectives/pediatric-development-plans/ 2024-08-22T10:05:33+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1224403019_abstract.jpg https://cytel.agencyukdev.com/perspectives/planning-strategies-for-externally-controlled-trials-insights-from-ispor-us-2024/ 2024-08-22T10:05:49+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1364191123_abstract.jpg https://cytel.agencyukdev.com/perspectives/platform-trials-can-they-benefit-animal-studies/ 2024-08-22T10:06:25+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/platform-trials-master-protocols-and-challenges-in-execution/ 2024-08-22T10:06:42+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-12.jpg https://cytel.agencyukdev.com/perspectives/presenting-clinical-data-for-regulatory-submission-a-stats-perspective/ 2024-08-22T10:07:17+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Florence-Le-Maulf_Intro-to-ISS-ISE_Fig1.webp https://cytel.agencyukdev.com/hubfs/Florence%20Le%20Maulf%20ISS%20ISE%20Presentation%20photo.png https://cytel.agencyukdev.com/perspectives/preserving-trial-integrity-after-receiving-an-unanticipated-idmc-recommendation/ 2024-08-22T10:07:41+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1459944177_abstract.jpg https://cytel.agencyukdev.com/perspectives/quantifying-uncertainty-in-rwe-studies-with-quantitative-bias-analysis/ 2024-08-22T10:08:34+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Hsu_QBA-workshop_Fig1.webp https://cytel.agencyukdev.com/perspectives/quantitative-strategies-for-rare-disease-clinical-trials/ 2024-08-22T10:08:51+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/raising-awareness-for-additional-fda-data-standards-submission-recommendations-part-ii/ 2024-08-22T10:09:08+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/raising-the-awareness-for-additional-fda-data-submission-recommendations-part-i/ 2024-08-22T10:09:24+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/real-life-data-sharing-and-eu-joint-clinical-assessments-is-closing-this-chasm-a-mission-impossible/ 2024-08-22T10:09:41+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Sarri_EUnetHTA_Fig1.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Sarri_EUnetHTA_Fig2.webp https://cytel.agencyukdev.com/perspectives/reducing-independent-data-monitoring-committee-timelines-a-focus-on-formal-interim-analyses/ 2024-08-22T10:09:55+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-03.jpg https://cytel.agencyukdev.com/perspectives/reflections-on-the-rct-duplicate-study-and-increasing-confidence-in-real-world-evidence/ 2024-08-22T10:10:13+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/reinforcement-learning-a-promising-tool-for-predicting-optimal-treatment-in-complex-diseases/ 2024-08-22T10:10:26+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/retrospective-claims-data-analysis-unlocks-discovery-in-multiple-sclerosis-research/ 2024-08-22T10:10:45+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1135527896_abstract.jpg https://cytel.agencyukdev.com/perspectives/sample-size-re-estimation-for-rare-disease-clinical-trials/ 2024-08-22T10:13:35+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-09.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Adler_Mazzanti_Sample-Size-Re-Estimation-for-Rare-Disease-Clinical-Trials_Fig1.webp https://cytel.agencyukdev.com/perspectives/setting-expectations-for-formal-interim-analyses-with-independent-data-monitoring-committees/ 2024-08-22T10:13:56+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1364191123-_abstract-scaled.jpg https://cytel.agencyukdev.com/perspectives/simulation-guided-design-for-biotechs/ 2024-08-22T10:14:16+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/society-of-clinical-trials-names-together-trial-of-the-year/ 2024-08-22T10:14:37+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/David_Sackett_Award_White_Blog_Thumbnail_1104_736-V1-1.webp https://cytel.agencyukdev.com/perspectives/strategies-for-selecting-new-indications-for-a-platform-trial/ 2024-08-22T10:15:40+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-06.jpg https://cytel.agencyukdev.com/perspectives/strategies-to-overcome-limited-patient-population-challenges-in-rare-disease-studies/ 2024-08-22T10:15:57+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1364191123_abstract.jpg https://cytel.agencyukdev.com/perspectives/submitting-software-programs-to-the-regulatory-agencies/ 2024-08-22T10:16:16+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-05.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/image-png-Dec-18-2020-07-22-51-20-AM.webp https://cytel.agencyukdev.com/perspectives/subpopulations-in-clinical-trial-design-thinking-through-hypothesis-testing/ 2024-08-22T10:18:02+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-957206588_abstract-scaled.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/image-png-Jun-11-2024-09-46-55-5720-AM.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/image-png-Jun-11-2024-09-46-55-5720-AM-1.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/image-png-Jun-11-2024-09-48-40-1972-AM.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/image-png-Jun-11-2024-09-53-00-4719-AM.webp https://cytel.agencyukdev.com/perspectives/supercharging-quantitative-decision-making-with-simulation-guided-trial-design/ 2024-08-22T10:18:18+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/the-case-for-network-meta-interpolation-to-handle-effect-modifiers-in-indirect-treatment-comparisons/ 2024-08-22T10:18:37+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/the-changing-landscape-of-the-pharmaceutical-industry-a-preview-of-cytels-contributions-at-phuse-eu-2023/ 2024-08-22T10:19:21+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/the-evolution-of-open-source-initiatives-and-new-standards-development-for-the-data-submission-of-the-future/ 2024-08-22T10:19:37+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/the-facts-in-the-case-of-subject-x/ 2024-08-22T10:19:54+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1224403019_abstract.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/GDD_The-Facts-in-the-Case-of-Subject-X_Fig-1.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/GDD_The-Facts-in-the-Case-of-Subject-X_Fig-2.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/GDD_The-Facts-in-the-Case-of-Subject-X_Fig-3.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/GDD_The-Facts-in-the-Case-of-Subject-X_Fig-4.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/GDD_The-Facts-in-the-Case-of-Subject-X_Fig-5.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/GDD_The-Facts-in-the-Case-of-Subject-X_Fig-6.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/GDD_The-Facts-in-the-Case-of-Subject-X_Fig-7.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/GDD_The-Facts-in-the-Case-of-Subject-X_Fig-8.webp https://cytel.agencyukdev.com/perspectives/the-fdas-new-draft-guidance-on-dmcs-what-to-know/ 2024-08-22T10:20:11+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1135527896_abstract.jpg https://cytel.agencyukdev.com/perspectives/the-living-model-approach-for-systematic-literature-reviews/ 2024-08-22T10:20:28+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/the-need-for-a-living-approach-to-htas/ 2024-08-22T10:20:56+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/ISPOR-Eu-banners_Grammati-2.webp https://cytel.agencyukdev.com/perspectives/the-need-for-structured-tools-to-guide-hta-submissions/ 2024-08-22T10:21:14+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/ISPOR-P1-Bart-banner.webp https://cytel.agencyukdev.com/perspectives/the-new-eu-hta-landscape-insights-on-indirect-evidence/ 2024-08-22T10:21:28+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1364191123-_abstract-scaled.jpg https://cytel.agencyukdev.com/perspectives/the-role-of-key-opinion-leaders-in-rare-disease-clinical-trials/ 2024-08-22T11:33:09+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-11.jpg https://cytel.agencyukdev.com/perspectives/the-together-trial-journey-interview-with-ofir-harari/ 2024-08-22T11:33:31+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/the-uses-of-bayesian-methods-in-late-phase-clinical-trial-strategy/ 2024-08-22T11:33:50+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/u-s-drug-pricing-reform-potential-impact-on-pharma-heor-evidence-generation/ 2024-08-22T11:34:07+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/ulrika-andersson-on-first-in-human-clinical-trial-development/ 2024-08-22T11:34:24+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1459944177_abstract.jpg https://cytel.agencyukdev.com/perspectives/understanding-group-sequential-designs/ 2024-08-22T11:34:41+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1224403019_abstract.jpg https://cytel.agencyukdev.com/perspectives/understanding-head-to-head-clinical-trials/ 2024-08-22T11:35:00+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/understanding-market-exclusivity-for-orphan-drug-products/ 2024-08-22T11:36:18+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-957206588_abstract-scaled.jpg https://cytel.agencyukdev.com/perspectives/understanding-master-protocol-designs-platform-and-basket-trials/ 2024-08-22T11:36:49+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1470900675_abstract.jpg https://cytel.agencyukdev.com/perspectives/understanding-the-economic-benefits-of-platform-trials/ 2024-08-22T11:37:27+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/unravelling-pico-the-pillars-of-the-european-joint-clinical-assessment/ 2024-08-22T11:37:45+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-07.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Rizzo_Unravelling-PICO_Fig1.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Rizzo_Unravelling-PICO_Fig2.webp https://cytel.agencyukdev.com/perspectives/use-of-rolling-enrollment-designs-to-accelerate-clinical-trials/ 2024-08-22T11:38:03+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1388001249-scaled.jpg https://cytel.agencyukdev.com/perspectives/using-quantitative-bias-analysis-in-real-world-data-strategy/ 2024-08-22T11:38:17+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1459944177_abstract.jpg https://cytel.agencyukdev.com/perspectives/visualizing-adam-a-practical-guide-through-examples/ 2024-08-22T11:38:37+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1364191123_abstract.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Faini_ADaM_Image1.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Faini_ADaM_Fig1.1.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Faini_ADaM_Fig2.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Faini_ADaM_Fig3.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Faini_ADaM_Fig3.3.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Faini_ADaM_Fig4.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Faini_ADaM_Fig4.2.webp https://cytel.agencyukdev.com/perspectives/watch-out-the-fda-rejection-criteria-are-now-in-place/ 2024-08-22T11:38:55+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-957206588_abstract-scaled.jpg https://cytel.agencyukdev.com/perspectives/what-it-means-to-be-a-lead-analyst-on-a-global-covid-19-trial/ 2024-08-22T11:39:11+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1459944177_abstract.jpg https://cytel.agencyukdev.com/perspectives/whats-ahead-for-clinical-trial-design/ 2024-08-22T11:39:27+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/why-and-when-to-use-profile-likelihood-based-confidence-intervals/ 2024-08-22T11:39:47+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-11.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Ashwini_LogXact_Post_Correction_Pic.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/ashwini_logxact_post_correction_pic_2.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/ashwini_logxact_post_correction_4.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/ashwini_logxact_post_correction_pic_3.webp https://cytel.agencyukdev.com/perspectives/why-are-there-not-more-bayesian-clinical-trials/ 2024-08-22T11:40:24+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/why-simulate-study-design-at-a-large-scale-leveraging-cloud-computing-for-confident-results/ 2024-08-22T11:40:45+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/writing-a-successful-study-protocol-for-real-world-evidence-studies/ 2024-08-22T11:41:26+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1470900662_abstract.jpg https://cytel.agencyukdev.com/perspectives/understanding-the-critical-role-of-dmcs-in-oncology-studies/ 2024-08-22T18:15:28+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1470900662_abstract.jpg https://cytel.agencyukdev.com/perspectives/career-perspectives-a-conversation-with-stephanie-brandt/ 2024-08-23T14:00:07+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-04.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/08/sbrandt3.png https://cytel.agencyukdev.com/wp-content/uploads/2024/08/steph-and-jake-scaled.jpg https://cytel.agencyukdev.com/perspectives/preparing-your-integrated-summaries-of-safety-and-effectiveness-best-practices/ 2024-08-29T11:58:12+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/perspectives/sas-vs-r-in-clinical-development/ 2024-09-03T14:00:19+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-01.jpg https://cytel.agencyukdev.com/perspectives/opportunities-and-pitfalls-of-using-ai-ml-in-clinical-development/ 2024-09-04T14:21:45+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/Cytel_web_abstract-08.jpg https://cytel.agencyukdev.com/perspectives/oncology-clinical-trials-design-trends-in-biomarker-research/ 2024-09-05T13:59:59+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-1224403019_abstract.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/08/2408-oncology-webinar-blog.png https://cytel.agencyukdev.com/perspectives/unlocking-germanys-pharmaceutical-market-a-guide-to-amnog-and-market-access/ 2024-10-17T17:39:47+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-626349894_abstract-e1718646801522.jpg https://cytel.agencyukdev.com/perspectives/career-perspectives-a-conversation-with-guillaume-herve/ 2024-10-29T14:29:23+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/05/iStock-2069659353_abstract-scaled.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/10/Guillaume-Herve.jpg https://cytel.agencyukdev.com/perspectives/standards-and-open-source-hand-in-hand-leveraging-automation-to-expedite-drug-market-request-review-process/ 2024-11-19T12:15:26+00:00 https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Cytel_Abstract_1.jpg https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Tinazzi_HandtoHand_Fig1.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Tinazzi_HandtoHand_Fig2.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Tinazzi_HandtoHand_Fig3.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/Tinazzi_HandtoHand_Fig4.webp https://cytel.agencyukdev.com/wp-content/uploads/2024/06/GDD_8.9.23_Hand-in-Hand_Conf-Image.webp